Sameer Awsare MD Archives

Dr. Awsare: Biosimilars in an integrated model help lower drug costs

March 19, 2024

Sameer Awsare, MD, tells Pink Sheet that Kaiser Permanente’s unique integrated structure helps it succeed in adopting biosimilars, resulting in lower drug costs for patients without sacrificing safety and efficacy.

Sameer Awsare, MD, discusses leveraging technology to provide 24/7 health care access

March 4, 2020

Sameer Awsare, MD, FACP, associate executive director of The Permanente Medical Group (TPMG), was quoted in a recent Modern Healthcare story on the rise of concierge services and innovative, technology-based access to health care in the San Francisco Bay Area.

Sameer Awsare, MD, discusses Permanente perspective on biosimilars

February 7, 2020

Sameer Awsare, MD, associate executive director for The Permanente Medical Group, shared in Biosimilars Development how Kaiser Permanente is a leader in the use of biosimilars.

Sameer Awsare, MD, highlights Kaiser Permanente model in case for biosimilars market

December 19, 2019

Physician leader Sameer Awsare, MD, FACP, co-writes an article in Health Affairs encouraging competition in the biosimilar drugs market to help curb rising health care costs.

Sameer Awsare, MD, focuses on Kaiser Permanente’s innovative approach to biosimilars at GRx+Biosims

November 8, 2019

Presenting at this week’s GRx+Biosims meeting in North Bethesda, Maryland, Sameer Awsare, MD, associate executive director of The Permanente Medical Group, elaborated on how Kaiser Permanente leverages its integrated care model to drive collaboration in advancing the move to biosimilars.

Tweetcap: U.S. Chamber of Commerce’s 2019 Health Care Summit spotlights business of health

November 1, 2019

The U.S. Chamber of Commerce hosted its 2019 Health Care Summit, "The Business of Health: Transforming with Transparency," in Washington, D.C. on Thursday, October 31.

The path to true transparency

August 7, 2019

Sameer Awsare, MD, FACP, focuses on government rules and state laws attempting to hold pharmaceutical companies accountable to escalating prescription drug prices, and asks what's true transparency?

Podcast: Permanente Medicine’s prescription for the opioid epidemic

April 15, 2019

This first podcast for 2019 includes Permanente physician leaders’ insights and best practices on tackling the epidemic of opioid abuse and addiction.

Sameer Awsare, MD, breaks down the basics of biosimilars

March 7, 2019

During a public briefing at the Alliance for Health Policy, Sameer Awsare, MD, of The Permanente Medical Group, joined other health care leaders to explain the mechanisms of biosimilar drugs.